Related Experiment Video
Updated: Sep 21, 2025
12:24
Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
Published on: July 17, 2012
12.5K
Nanotheranostics for Image-Guided Cancer Treatment
Isabel S Dennahy1, Zheng Han1, William M MacCuaig2
1Department of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA.
Pharmaceutics
|May 28, 2022
Summary
Image-guided nanotheranostics offer a new approach to cancer treatment by combining imaging precision with targeted drug delivery. This strategy aims to overcome chemotherapy
Area of Science:
- Oncology
- Nanotechnology
- Medical Imaging
Background:
- Conventional chemotherapy faces challenges like side effects and drug resistance.
- Modern imaging and nanoparticle design advancements offer potential solutions.
- Tailoring cancer therapies requires precise drug delivery and monitoring.
Purpose of the Study:
- To review image-guided nanotheranostics for cancer treatment.
- To discuss targeted drug delivery mechanisms and nanotheranostic design.
- To examine current clinical applications and future directions.
Main Methods:
- Review of traditional targeted drug delivery in cancer.
- Exploration of nanotheranostic design principles and nanoparticle labeling for imaging.
- Analysis of newer image-guided drug delivery concepts.
- Discussion of barriers to clinical translation.
Main Results:
- Nanotheranostics leverage imaging to direct, dictate, and monitor site-specific drug delivery.
- Engineered nanoparticles and labeling strategies enhance detectability in various imaging modalities.
- Preclinical and clinical trials show significant progress, though clinical translation is nascent.
Conclusions:
- Image-guided nanotheranostics represent a promising paradigm shift in personalized cancer therapy.
- Overcoming clinical translation barriers is crucial for widespread adoption.
- Further research into novel delivery concepts can circumvent existing limitations.
